Ductal carcinoma in situ of breast: update 2019.

Ductal carcinoma in situ is a non-invasive form of breast cancer. Its incidence is increasing due to widespread use of mammographic screening. It presents several diagnostic and management challenges in part due to its relatively indolent behaviour. Most series analysing biomarkers in these lesions are small (<100 patients) and large clinical trials have not been frequent. Herein, we review the recent progress made in understanding the biology of this entity and the tools available for prognostication.

• Publication year

  2019

• Venue

  Pathology (Sydney)

• Publication date

  2019-08-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pathol.2019.07.005PMID 31472981PMCID PMC6788802
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Variability in diagnostic threshold for comedo necrosis among breast pathologists: implications for patient eligibility for active surveillance trials of ductal carcinoma in situ

  2019cited by this paper
• Morphologic and Molecular Features of Breast Ductal Carcinoma in Situ.

  2019cited by this paper
• Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.

  2019cited by this paper
• The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast

  2018cited by this paper
• Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence

  2018cited by this paper
• American Society of Breast Surgeons’ Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation

  2018cited by this paper
• Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.

  2018cited by this paper
• Prediction of Occult Invasive Disease in Ductal Carcinoma in Situ Using Deep Learning Features.

  2018cited by this paper
• Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast

  2018cited by this paper
• A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

  2018cited by this paper
• Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer

  2018cited by this paper
• Breaking through to the Other Side: Microenvironment Contributions to DCIS Initiation and Progression

  2018cited by this paper
• Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers

  2018cited by this paper
• Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation

  2017cited by this paper
• A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease

  2017cited by this paper
• Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features

  2017cited by this paper
• Anti-angiogenic treatment in breast cancer: Facts, successes, failures and future perspectives.

  2017cited by this paper
• Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials

  2017cited by this paper
• Single cell heterogeneity in ductal carcinoma in situ of breast

  2017cited by this paper
• Mapping genomic and transcriptomic alterations spatially in epithelial cells adjacent to human breast carcinoma

  2017cited by this paper
• Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer

  2017cited by this paper
• Breast cancer statistics, 2017, racial disparity in mortality by state

  2017cited by this paper
• Transcriptome evolution from breast epithelial cells to basal-like tumors

  2017cited by this paper
• Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast.

  2017cited by this paper
• Copy number profiling of oncogenes in ductal carcinoma in situ of the male breast.

  2017cited by this paper
• Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ

  2017cited by this paper
• The immune microenvironment of breast ductal carcinoma in situ

  2016cited by this paper
• Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast

  2016cited by this paper
• Do LORIS Trial Eligibility Criteria Identify a Ductal Carcinoma In Situ Patient Population at Low Risk of Upgrade to Invasive Carcinoma?

  2016cited by this paper
• Society of Surgical Oncology–American Society for Radiation Oncology–American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ

  2016cited by this paper
• Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

  2016cited by this paper
• Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer

  2016cited by this paper
• Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer

  2015cited by this paper
• The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.

  2015cited by this paper
• Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.

  2015cited by this paper
• Copy number analysis of ductal carcinoma in situ with and without recurrence

  2015cited by this paper
• Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration

  2015cited by this paper
• Upgrade of ductal carcinoma in situ on core biopsies to invasive disease at final surgery: a retrospective review across the Scottish Breast Screening Programme.

  2015cited by this paper
• Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study.

  2015cited by this paper
• Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis

  2015cited by this paper
• Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

  2015cited by this paper
• Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion

  2014cited by this paper
• PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

  2014cited by this paper
• Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.

  2014cited by this paper
• Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

  2014cited by this paper
• Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

  2014cited by this paper
• Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

  2014cited by this paper
• Supplementary Appendix

  2013cited by this paper
• A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

  2013cited by this paper
• Breast Cancer Statistics

  2013cited by this paper
• Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression

  2012cited by this paper
• Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24.

  2012cited by this paper
• Correlation between the DCIS score and traditional clinicopathologic features in the prospectively designed E5194 clinical validation study.

  2012cited by this paper
• Breast cancer statistics, 2011

  2011cited by this paper
• Fine Tuning of the Van Nuys Prognostic Index (VNPI) 2003 by Integrating the Genomic Grade Index (GGI): New Tools for Ductal Carcinoma In Situ (DCIS)

  2011cited by this paper
• Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.

  2011cited by this paper
• Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

  2011cited by this paper
• Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review

  2011cited by this paper
• Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling

  2011cited by this paper
• Prognostic markers and long‐term outcomes in ductal carcinoma in situ of the breast treated with excision alone

  2011cited by this paper
• Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer

  2010cited by this paper
• National Institutes of Health State-of-the-Science Conference statement: Diagnosis and Management of Ductal Carcinoma In Situ September 22-24, 2009.

  2010cited by this paper
• Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study

  2010cited by this paper
• Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis.

  2010cited by this paper
• Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ.

  2010cited by this paper
• Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group.

  2009cited by this paper
• College of American Pathologists protocol for the reporting of ductal carcinoma in situ.

  2009cited by this paper
• Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

  2008cited by this paper
• Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only

  2006cited by this paper
• Classification of ductal carcinoma in situ by gene expression profiling

  2006cited by this paper
• Gene expression profiling of ductal carcinomas in situ and invasive breast tumors.

  2003cited by this paper
• Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight‐year update of Protocol B‐17

  1999cited by this paper
• Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.

  1998cited by this paper
• Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast.

  1995cited by this paper
• Prognostic classification of breast ductal carcinoma-in-situ.

  1995cited by this paper
• Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.

  1995cited by this paper
• Pathologic findings from the national surgical adjuvant breast project protocol B‐06 10‐year pathologic and clinical prognostic discriminants

  1993cited by this paper

• Pure Ductal Carcinoma in Situ: Clinicopathological Experience from a Single Tertiary Care Center

  2026cites this paper
• Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ: A Phase 1 Nonrandomized Clinical Trial.

  2025cites this paper
• Association between Depression and Social Isolation among Women with Breast Cancer

  2025cites this paper
• Fast multimodal imaging combined with machine learning identifying taurine as a potential marker for breast cancer margin assessment

  2025cites this paper
• Clinical and morphological characteristics of intraductal carcinoma in situ of the mammary gland

  2025cites this paper
• RPL17 regulates the progression of breast cancer accompanied by MAPK signaling activation

  2025cites this paper
• Case Report: Sneaky DCIS-like invasive ductal carcinoma of the breast in the setting of extensive DCIS

  2025cites this paper
• Prediction of intraductal cancer microinfiltration based on the hierarchical fusion of peri-tumor imaging histology and dual view deep learning

  2025cites this paper
• Epigenetic regulation of breast ductal carcinoma in situ by miR‐217 through DNMT1 and Hedgehog‐GLI pathway

  2025cites this paper
• Prediction of upstaging in DCIS: the dominant role of pathological over imaging risk factors

  2025influential citation
• Can Mammography and Magnetic Resonance Imaging Predict the Preoperative Size and Nuclear Grade of Pure Ductal Carcinoma In Situ?

  2025cites this paper
• The DCIS–IBC guide board on predicting postoperative upgrading in breast ductal carcinoma in situ: clinical insights from a multicenter study

  2025cites this paper
• Nanostructured Formulations for a Local Treatment of Cancer: A Mini Review About Challenges and Possibilities

  2025cites this paper
• Advancements in the Application of Convolutional Neural Networks in Ultrasound Imaging for Breast Cancer Diagnosis and Treatment

  2025cites this paper
• Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ

  2024cites this paper
• CD147 expression in breast cancer and its association with tumor clinicopathological features

  2024cites this paper
• Changes to the US Preventive Services Task Force Screening Guidelines and Incidence of Breast Cancer

  2024cites this paper
• Advancements in Managing Pure Ductal Carcinoma In Situ: An 18-Year Artificial Intelligence-Aided Analysis of 998 Patients

  2024cites this paper
• Evaluation of tumor infiltrating lymphocytes as a prognostic biomarker in patients with ductal carcinoma in situ of the breast

  2024cites this paper
• Comparison of locoregional recurrence risk among nipple-sparing mastectomy, skin-sparing mastectomy, and simple mastectomy in patients with ductal carcinoma in situ: a single-center study

  2024cites this paper
• Upper Extremity Deep Vein Thrombosis in the Setting of Ductal Carcinoma In Situ: A Case Report

  2024cites this paper
• Comparison of the effectiveness of contrast-enhanced mammography in detecting malignant lesions in patients with extremely dense breasts compared to the all-densities population

  2024cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance

  2024cites this paper
• Male ductal carcinoma in situ: diagnosis and management of a rare disease in men

  2024cites this paper
• Age and race/ethnicity differences in decisional conflict in women diagnosed with ductal carcinoma in situ

  2024cites this paper
• Tumor microenvironmental determinants of high-risk DCIS progression

  2024cites this paper
• Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study.

  2023cites this paper
• Polysulfide Serves as a Hallmark of Desmoplastic Reaction to Differentially Diagnose Ductal Carcinoma In Situ and Invasive Breast Cancer by SERS Imaging

  2023cites this paper
• Neoductgenesis in Ductal Carcinoma In Situ Coexists with Morphological Abnormalities Characteristic for More Aggressive Tumor Biology

  2023cites this paper
• Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model

  2023cites this paper
• Emerging Targeted Therapies for HER2-Positive Breast Cancer

  2023cites this paper
• Active Surveillance for Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ.

  2023cites this paper
• The imaging appearances of non‐calcified ductal carcinoma in situ: A pictorial essay

  2023influential citation
• Clinicopathological characteristics and recurrence risk in patients with ductal carcinoma in situ of the breast

  2023cites this paper
• BIRADS 4 - Is it possible to downgrade lesions that do not enhance on recombinant contrast-enhanced mammography images?

  2023cites this paper
• A clinical radiomics nomogram preoperatively to predict ductal carcinoma in situ with microinvasion in women with biopsy-confirmed ductal carcinoma in situ: a preliminary study

  2023cites this paper
• Treatments and Prognosis of the Breast Ductal Carcinoma In Situ.

  2023cites this paper
• Nanostructured lipid carriers loaded into in situ gels for breast cancer local treatment.

  2023cites this paper
• Collagen-Binding Nanoparticles for Paclitaxel Encapsulation and Breast Cancer Treatment

  2023cites this paper
• Pathological underestimation and biomarkers concordance rates in breast cancer patients diagnosed with ductal carcinoma in situ at preoperative biopsy

  2022cites this paper
• Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed.

  2022cites this paper
• The accuracy of magnetic resonance imaging in predicting the size of pure ductal carcinoma in situ: a systematic review and meta-analysis

  2022cites this paper
• Canine and feline in situ mammary carcinoma: A comparative review

  2022cites this paper
• Annual cost-savings with the implementation of estrogen-receptor-only testing on Ductal Carcinoma in Situ specimens.

  2022cites this paper
• Is conservative management of ductal carcinoma in situ risky?

  2022cites this paper
• Is conservative management of ductal carcinoma in situ risky?

  2022cites this paper
• Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018

  2022cites this paper
• Healthy lifestyle index and the risk of ductal carcinoma in situ of the breast in the Women's Health Initiative

  2022cites this paper
• Screen-detected ductal carcinoma in situ, 2008–2020: An observational study

  2022cites this paper
• Exploration of the breast ductal carcinoma in situ signature and its prognostic implications

  2022cites this paper
• Ductal carcinoma in situ of breast: from molecular etiology to therapeutic management.

  2022cites this paper
• Outcome and risk factors for local recurrence after breast conserving surgery in patients affected by ductal carcinoma in situ.

  2022cites this paper
• The Ultrasonographic Characteristics of Focal Fibrocystic Change of the Breast and Analysis of Misdiagnosis.

  2021cites this paper
• Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling

  2021cites this paper
• Clinicopathological Characteristics of Breast Ductal Carcinoma In Situ: An Analysis of Chinese Population of 617 Patients

  2021cites this paper
• Obesity, Metabolic Syndrome & Breast Cancer – short review

  2021cites this paper
• DCIS in Male and Aged Women with Comorbidities.

  2021cites this paper
• Epidemiology of Ductal Carcinoma In Situ.

  2021cites this paper
• Imaging Diagnosis of Ductal Carcinoma In Situ.

  2021cites this paper
• A Clinical Case Study of Synchronous Breast Cancer

  2021cites this paper
• The Single-Cell Sequencing: A Dazzling Light Shining on the Dark Corner of Cancer

  2021cites this paper
• Exploration of Core Genes Signature and Prognostic Implication for Ductal Carcinoma In Situ of the Breast

  2021cites this paper
• Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion

  2021cites this paper
• Survival analysis of patients with primary breast duct carcinoma and lung adenocarcinoma: a population-based study from SEER

  2021cites this paper
• Is There a Role of Adjuvant Irradiation for Patientswith Ductal Carcinoma in Situ (DCIS) Undergoing Breast Conserving Surgery (BCS)?

  2020cites this paper
• Emerging Cancer Epigenetic Mechanisms Regulated by All-Trans Retinoic Acid

  2020cites this paper
• Prognostic model of invasive ductal carcinoma of the breast based on differentially expressed glycolysis-related genes

  2020cites this paper
• A Biological Signature for Breast Ductal Carcinoma In Situ to Predict Radiotherapy Benefit and Assess Recurrence Risk

  2018cites this paper